Levetiracetam 750 mg/1 (Levetiracetam TABLET, FILM COATED) 750 mg/1

Levetiracetam 750 mg tablets are an anticonvulsant medication used to manage certain types of seizures. This film-coated tablet is designed for oral administration and is commonly prescribed for epilepsy treatment.

Strength

750 mg/1

Pack Size

100 BLISTER PACK in 1 CARTON (0904-7125-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Major Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levetiracetam is primarily used as an anticonvulsant to control partial onset seizures in adults and children. It is often prescribed for epilepsy management, helping to reduce the frequency and severity of seizures. Levetiracetam works by affecting certain chemicals in the brain that may be involved in causing seizures.

Side Effects

Common effects of Levetiracetam may include drowsiness, dizziness, and fatigue. Some users may experience headache, nausea, or irritability. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Levetiracetam should be handled with care, especially for individuals with a history of mental health conditions. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Levetiracetam may interact with other medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain CYP inhibitors may also affect the efficacy of Levetiracetam.

Frequently Asked Questions

Levetiracetam is primarily used to manage partial onset seizures in adults and children with epilepsy.

Levetiracetam is taken orally, typically as a film-coated tablet, and should be used as directed by a healthcare provider.

Common side effects may include drowsiness, dizziness, fatigue, headache, nausea, and irritability.

Levetiracetam may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Levetiracetam can be purchased from licensed online pharmacies, but it is essential to ensure the source is reputable.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.